Teva Pharmaceuticals USA, Inc. is voluntarily recalling 43,696 cartons of Octreotide Acetate for Injectable Suspension (10 mg, 20 mg, and 30 mg strengths) because of quality system deficiencies at the contract manufacturer that mean the sterility of the product cannot be guaranteed. This drug is a prescription medication used via gluteal intramuscular injection. Consumers should be aware that using a non-sterile injectable medication can lead to serious, potentially life-threatening infections.
Deficiencies in the manufacturer's quality system mean the sterility of these injectable vials is not assured. Injecting a product that is not sterile can introduce bacteria or other contaminants directly into the body, posing a risk of severe localized or systemic infections.
Manufactured in Greece by Pharmathen International S.A.
Manufactured in Greece by Pharmathen International S.A.
Manufactured in Greece by Pharmathen International S.A.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.